Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

What’s the harm? Risks and benefits of evolving rule-out sepsis practices

Abstract

Asymptomatic term and late-preterm newborns with risk factors for early onset sepsis commonly undergo laboratory evaluation and receive empiric antibiotic therapy. Some have challenged the rationale for current “rule-out sepsis” practices, arguing that they lead to unnecessary overtreatment and healthcare costs. A series of recent clinical studies has explored scheduled serial observations as an alternative to laboratory testing and empiric antibiotics for asymptomatic newborns with historical risk factors for sepsis. These studies have shared the conclusion that serial observation is safe and cost-effective for well-appearing term and late-preterm babies, but they are also somewhat speculative because culture-proven early onset sepsis is an extremely low prevalence diagnosis. Here, we review the evolving consensus of optimal rule-out sepsis practices. We examine chorioamnionitis as an example of a problematic risk factor that has contributed to the controversy surrounding this topic. We also discuss how introduction of online sepsis risk calculators has allowed more precise delineation of a patient’s chances of developing culture-proven infection. Finally, we analyze existing data from published studies to estimate the number needed to harm (NNH) when an observation-based strategy is used instead of a risk-based approach. We conclude that, if harm is defined as death or serious sepsis complications such as hemodynamic instability or neurologic injury, the NNH is 1610, compared to an NNH of 7 and 2.9 for IV infiltrates and delayed breastfeeding, respectively—two common and potentially consequential complications of NICU admission for a rule-out sepsis. We believe that the differential between risk of serious harm from observing a well-appearing term or late-preterm newborn with risk factors for sepsis and the risk of less significant but common NICU complications argues in favor of the ongoing trend toward less aggressive management of newborns with sepsis risks.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR. 2010;59:1–36.

    PubMed  Google Scholar 

  2. Polin RA, Committee on F, Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.

    Article  PubMed  Google Scholar 

  3. National Collaborating Centre for Women’s and Children’s Health (UK). Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. London: RCOG Press: 2012 (NICE Clinical Guidelines, No. 149.) https://www.ncbi.nlm.nih.gov/books/NBK116610/.

  4. Buckler B, Bell J, Sams R, Cagle W, Bell SA, Allen C, et al. Unnecessary workup of asymptomatic neonates in the era of group B streptococcus prophylaxis. Infect Dis Obstet Gynecol. 2010;2010:369654.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Paxton RD, Byington CL. An examination of the unintended consequences of the rule-out sepsis evaluation: a parental perspective. Clin Pediatr. 2001;40:71–77.

    Article  CAS  Google Scholar 

  6. Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr. 2015;166:1070–4.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hooven TA, Polin RA. Time to overhaul the “rule out sepsis” workup. Pediatrics. 2017;140:e20171155.

    Article  PubMed  Google Scholar 

  8. Flidel-Rimon O, Galstyan S, Juster-Reicher A, Rozin I, Shinwell ES. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr. 2012;101:e540–544.

    Article  PubMed  Google Scholar 

  9. Wortham JM, Hansen NI, Schrag SJ, Hale E, Van Meurs K, Sanchez PJ, et al. Chorioamnionitis and culture-confirmed, early-onset neonatal infections. Pediatrics. 2016;137:e20152323

    Article  PubMed Central  Google Scholar 

  10. Mukhopadhyay S, Lieberman ES, Puopolo KM, Riley LE, Johnson LC. Effect of early-onset sepsis evaluations on in-hospital breastfeeding practices among asymptomatic term neonates. Hosp Pediatr. 2015;5:203–10.

    Article  PubMed  Google Scholar 

  11. Murgas Torrazza R, Neu J. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol. 2011;31(Suppl 1):S29–34.

    Article  PubMed  Google Scholar 

  12. Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC, Puopolo KM. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics. 2014;133:196–203.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol. 2013;33:198–205.

    Article  PubMed  CAS  Google Scholar 

  14. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol. 1999;94:274–8.

    PubMed  CAS  Google Scholar 

  15. Seong HS, Lee SE, Kang JH, Romero R, Yoon BH. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol. 2008;199:375. e371-375

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rouse DJ, Landon M, Leveno KJ, Leindecker S, Varner MW, Caritis SN, et al. The maternal-fetal medicine units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol. 2004;191:211–6.

    Article  PubMed  Google Scholar 

  17. Romero R, Chaemsaithong P, Docheva N, Korzeniewski SJ, Kusanovic JP, Yoon BH, et al. Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity. J Perinat Med. 2016;44:33–51.

    PubMed  PubMed Central  CAS  Google Scholar 

  18. Gibbs RS. Diagnosis of intra-amniotic infection. Semin Perinatol. 1977;1:71–77.

    PubMed  CAS  Google Scholar 

  19. Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol. 1988;72:823–8.

    Article  PubMed  CAS  Google Scholar 

  20. Romero R, Chaemsaithong P, Korzeniewski SJ, Kusanovic JP, Docheva N, Martinez-Varea A, et al. Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection? J Perinat Med. 2016;44:23–32.

    PubMed  PubMed Central  CAS  Google Scholar 

  21. Gotsch F, Romero R, Chaiworapongsa T, Erez O, Vaisbuch E, Espinoza J, et al. Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med. 2008;21:605–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Combs CA, Gravett M, Garite TJ, Hickok DE, Lapidus J, Porreco R, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;210:125 e121–125 e115.

    Article  Google Scholar 

  23. Greenberg MB, Anderson BL, Schulkin J, Norton ME, Aziz N. A first look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol. 2012;2012:628362.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IA, Watterberg K, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127:426–36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Committee on Obstetric, P. Committee opinion No. 712: intrapartum management of intraamniotic infection. Obstet Gynecol. 2017;130:e95–e101. https://doi.org/10.1097/AOG.0000000000002236.

    Article  Google Scholar 

  26. DiGiulio DB, Romero R, Kusanovic JP, Gomez R, Kim CJ, Seok KS, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol. 2010;64:38–57.

    PubMed  PubMed Central  Google Scholar 

  27. Robbins JR, Bakardjiev AI. Pathogens and the placental fortress. Curr Opin Microbiol. 2012;15:36–43.

    Article  PubMed  Google Scholar 

  28. Jackson GL, Rawiki P, Sendelbach D, Manning MD, Engle WD. Hospital course and short-term outcomes of term and late preterm neonates following exposure to prolonged rupture of membranes and/or chorioamnionitis. Pediatr Infect Dis J. 2012;31:89–90.

    Article  PubMed  Google Scholar 

  29. Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics. 2014;133:992–8.

    Article  PubMed  Google Scholar 

  30. Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Stratification of risk of early-onset sepsis in newborns >/=34 weeks’ gestation. Pediatrics. 2014;133:30–36.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Garcia-Munoz Rodrigo F, Galan Henriquez GM, Ospina CG. Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis. Pediatr Neonatol. 2014;55:381–6.

    Article  PubMed  Google Scholar 

  32. Pappas A, Kendrick DE, Shankaran S, Stoll BJ, Bell EF, Laptook AR, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 2014;168:137–47.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Soraisham AS, Singhal N, McMillan DD, Sauve RS, Lee SK, Canadian Neonatal N. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol. 2009;200:372. e371-376

    Article  PubMed  Google Scholar 

  34. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103:e77.

    Article  PubMed  CAS  Google Scholar 

  35. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol. 1996;87:188–94.

    Article  PubMed  CAS  Google Scholar 

  36. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. NEJM. 2009;360:2626–36.

    Article  PubMed  Google Scholar 

  37. Malloy MH. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. J Perninatol. 2014;34:611–5.

    Article  CAS  Google Scholar 

  38. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011;128:e1155–1163.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.

    Article  PubMed  Google Scholar 

  40. Berardi A, Buffagni AM, Rossi C, Vaccina E, Cattelani C, Gambini L, et al. Serial physical examinations, a simple and reliable tool for managing neonates at risk for early-onset sepsis. World J Clin Pediatr. 2016;5:358–64.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Cantoni L, Ronfani L, Da Riol R, Demarini S. Perinatal study group of the region Friuli-Venezia G. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention’s 2010 recommendations. J Pediatr. 2013;163:568–73.

    Article  PubMed  Google Scholar 

  42. Jan AI, Ramanathan R, Cayabyab RG. Chorioamnionitis and management of asymptomatic infants >/=35 weeks without empiric antibiotics. Pediatrics. 2017;140:e20162744.

    Article  PubMed  Google Scholar 

  43. Berardi A, Fornaciari S, Rossi C, Patianna V, Bacchi Reggiani ML, Ferrari F, et al. Safety of physical examination alone for managing well-appearing neonates >/=35 weeks’ gestation at risk for early-onset sepsis. Matern Fetal Neonatal Med. 2015;28:1123–7.

    Article  Google Scholar 

  44. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr iInfect Dis J. 2003;22:430–4.

    Google Scholar 

  45. Joshi, N., Gupta A., Kim J., Weldon B., Cohen R., Aby J., Benitz W., Frymoyer A. Towards Safely Reducing Antibiotic Exposure and Laboratory Testing in Well-Appearing Newborns Born to Mothers with Chorioamnionitis. Pediatric Academic Societies Annual Meeting. Baltimore, MD. 2016

  46. Birhane E, Kidanu K, Kassa M, Gerezgiher D, Tsegay L, Weldu B, et al. Lifespan and associated factors of peripheral intravenous Cannula among infants admitted in public hospitals of Mekelle City, Tigray, Ethiopia, 2016. BMC Nurs. 2017;16:33.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Reynolds J. Comparison of percutaneous venous catheters and teflon catheters for intravenous therapy in neonates. Neonatal Netw. 1993;12:33–39.

    PubMed  CAS  Google Scholar 

  48. Garland JS, Dunne WM Jr., Havens P, Hintermeyer M, Bozzette MA, Wincek J, et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics. 1992;89:1145–50.

    PubMed  CAS  Google Scholar 

  49. Tobin CR. The teflon intravenous catheter: incidence of phlebitis and duration of catheter life in the neonatal patient. J Obstet Gynecol Neonatal Nurs. 1988;17:35–42.

    Article  PubMed  CAS  Google Scholar 

  50. Batton DG, Maisels MJ, Appelbaum P. Use of peripheral intravenous cannulas in premature infants: a controlled study. Pediatrics. 1982;70:487–90.

    PubMed  CAS  Google Scholar 

  51. Franck LS, Hummel D, Connell K, Quinn D, Montgomery J. The safety and efficacy of peripheral intravenous catheters in ill neonates. Neonatal Netw. 2001;20:33–38.

    Article  PubMed  CAS  Google Scholar 

  52. Legemaat M, Carr PJ, van Rens RM, van Dijk M, Poslawsky IE, van den Hoogen A. Peripheral intravenous cannulation: complication rates in the neonatal population: a multicenter observational study. J Vasc Access. 2016;17:360–5.

    Article  PubMed  Google Scholar 

  53. Johnson RV, Donn SM. Life span of intravenous cannulas in a neonatal intensive care unit. Am J Dis Child. 1988;142:968–71.

    PubMed  CAS  Google Scholar 

  54. Kostogloudis N, Demiri E, Tsimponis A, Dionyssiou D, Ioannidis S, Chatziioannidis I, et al. Severe extravasation injuries in neonates: a report of 34 cases. Pediatr Derm. 2015;32:830–5.

    Article  Google Scholar 

  55. Leung AK, Sauve RS. Breast is best for babies. J Natl Med Assoc. 2005;97:1010–9.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard A. Polin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hooven, T.A., Randis, T.M. & Polin, R.A. What’s the harm? Risks and benefits of evolving rule-out sepsis practices. J Perinatol 38, 614–622 (2018). https://doi.org/10.1038/s41372-018-0081-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-018-0081-3

This article is cited by

Search

Quick links